Out of 450 patients referred for thyroid scintigraphy 83 consecutive patients with nodular goitre were selected for dual scintigraphy with 99mTc and 123I. Seventy-four patients had one or more palpable nodules and the other nine patients had palpably diffuse goitres with one or more nodules on the routine 99mTc scintigram. For the comparison of scintigrams an eight level colour display was used, and regional differences between the 99mTc and 123I scintigrams were defined as a minimum of 25% (2 colour levels) variation of the relative activity in well defined areas.
Thirteen patients, i.e. 16% of those with nodular goitre, had discordant scintigrams. All 13 patients had non-malignant thyroid disorders, (simple goitre, radio-iodine treated hyperthyroidism, autonomous adenoma, subacute thyroiditis, Riedel's and lymphocytic thyroiditis). The diagnosis was verified histologically in eight of these patients.
Eight of the 13 patients had a high 99mTc activity relative to 123I, five patients showed the opposite discrepancy. Another 5 patients with a follicular or mixed follicular thyroid carcinoma had identical scintigrams.
These findings indicate that 123I does not offer such diagnostic advantages over the cheap and readily available 99mTc, that its use for routine scintigraphy of the thyroid gland seems to be justified at present.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Arnold, J.E., Pinsky, S.: Comparison of 99mTc and 123I for thyroid imaging. J. nucl. Med. 17, 261–267 (1976)
Atkins, H.L., Klopper, J.F., Lambrecht, R.M., Wolf, A.P.: A comparison of technetium 99m and iodine 123 for thyroid imaging. Amer. J. Roentgenol. Radium Ther. nucl. Med. 117, 195–201 (1973)
Cederquist, E., Naversten, Y., Persson, R.B.R., Strand, S.E., Svensson, L.: Comparative evaluation of 99mTc and 123I for thyroid scintigraphy and uptake measurements. Proceedings of XIII International Annual Meeting, Society of Nuclear Medicine, 166.1–166.7, Copenhagen (1975)
Dos Remedios, L.V., Weber, P.M., Jasko, I.A.: Thyroid scintiphotography in 1000 patients: Rational use of 99mTc and 131I compounds. J. nucl. Med. 12, 673–677 (1971)
Hauser, W., Atkins, H.L., Eckelman, W.C., Richards, P.: Thyroidal pertechnetate uptake in Hashimoto's disease. Amer. J. Roentgenol. Radium Ther. nucl. Med. 112, 720–725 (1971)
Quinn, J.L., Henkin, R.E.: Scanning techniques to assess thyroid nodules. Ann. Rev. Med. 26, 193–201 (1975)
Robertson, J.W.K., Shimmins, J., Horton, P.W., Lazarus, J.H., Alexander, W.D.: Determination of the rates of accumulation and loss of iodide and of proteinbinding of iodine in the human thyroid gland. In “Dynamic studies with radioisotopes in medicine 1974”, Vol. I, IAEA, Vienna, p. 353 (1974)
Shambaugh, G.E., Quinn, J.L., Oyasu, R., Freinkel, N.: Disparate thyroid imaging: Combined studies with 99mTc-sodium pertechnetate and radioactive iodine. JAMA 228, 866–869 (1974)
Steinberg, M., Cavalieri, R.R., Choy, S.H.: Uptake of technetium 99-pertechnetate in a primary thyroid carcinoma: Need for caution in evaluating nodules. J. clin. Endocrin. Metab. 31, 81–84 (1970)
Strauss, H.W., Hurley, P.J., Wagner, H.N.: Advantages of 99mTc pertechnetate for thyroid scanning in patients with decreased radioiodine uptake. Radiology 97, 307–310 (1970)
Turner, J.W., Spencer, R.P.: Thyroid carcinoma presenting a pertechnetate “hot” nodule, but without 131I uptake: Case report. J. nucl. Med. 17, 22–23 (1976)
Usher, M.S., Arzoumanian, A.Y.: Thyroid nodule scans made with pertechnetate and iodine may give inconsistent results. J. nucl. Med. 12, 136–137 (1971)
About this article
Cite this article
Dige-Petersen, H., Kroon, S., Vadstrup, S. et al. A comparison of 99mTc and 123I scintigraphy in nodular thyroid disorders. Eur J Nucl Med 3, 1–4 (1978). https://doi.org/10.1007/BF00253469
- Thyroid Carcinoma
- Thyroid Disorder
- Follicular Thyroid Carcinoma